Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 16, 2026 15:00 ET | Source: StarkAge Therapeutics

New Preclinical Data on STX-1, a First-in-Class Senolytic ADC, To Be Presented at AACR 2026

Presentations highlight therapy-induced senescence as a new opportunity and reinforce STX-1’s potential as a differentiated approach in solid tumors.
January 27, 2026 05:00 ET | Source: StarkAge Therapeutics

StarkAge Therapeutics Announces Research Collaboration with Gustave Roussy to Advance Senolytic Therapies in Digestive Cancers

The collaboration will inform patient selection for treatment with STX-1, a first-in-class senolytic ADC directed against DPP4/CD26.